Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Saura

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Breast Care (Basel, Switzerland)|October 16, 2018
From Standard of Care to the Neoadjuvant Model as an Innovative Platform for Exploring Promising Combinations in Breast CancerCristina Saura
Breast Care (Basel, Switzerland)|August 11, 2020
Tackling the Biological Diversity in Early Triple-Negative Breast CancerMafalda Oliveira, Cristina Saura
Cancer Drug Resistance (Alhambra, Calif.)|April 17, 2023
The change of paradigm in the treatment of HER2-positive breast cancer with the development of new generation antibody-drug conjugatesSantiago Escrivá-de-Romaní, Cristina Saura
JAMA|April 9, 2009
Risk of venous thromboembolism with bevacizumab in cancer patientsJavier Cortes, Cristina Saura, Francesco Atzori
Communications Medicine|May 10, 2025
Expanding screening through the use of liquid biopsy for early cancer detectionMarta Perachino, Carolina Ortiz, Javier Carmona, et al.
Breast (Edinburgh, Scotland)|April 10, 2018
HER2-positive breast cancer: Current and new therapeutic strategiesSantiago Escrivá-de-Romaní, Miriam Arumí, Meritxell Bellet, et al.
Clinical Colorectal Cancer|January 24, 2007
Novel targets for anticancer treatment development in colorectal cancerTeresa Macarulla, Francisco Javier Ramos, Jaume Capdevila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2020
Reply to T. J. A. Dekker, D.-C. Mo et al, and A. Seidman et alCristina Saura, Mafalda Oliveira, Sung-Bae Kim, et al.
Expert Review of Anticancer Therapy|September 1, 2020
Neratinib plus capecitabine for the treatment of advanced HER2-positive breast cancerMafalda Oliveira, Laia Garrigós, Juan David Assaf, et al.
Cancer Treatment Reviews|October 25, 2022
The conundrum of breast cancer and microbiome - A comprehensive review of the current evidenceAndri Papakonstantinou, Paolo Nuciforo, Maria Borrell, et al.
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Breast Care (Basel, Switzerland)|October 16, 2018
From Standard of Care to the Neoadjuvant Model as an Innovative Platform for Exploring Promising Combinations in Breast CancerCristina Saura
Breast Care (Basel, Switzerland)|August 11, 2020
Tackling the Biological Diversity in Early Triple-Negative Breast CancerMafalda Oliveira, Cristina Saura
Cancer Drug Resistance (Alhambra, Calif.)|April 17, 2023
The change of paradigm in the treatment of HER2-positive breast cancer with the development of new generation antibody-drug conjugatesSantiago Escrivá-de-Romaní, Cristina Saura
JAMA|April 9, 2009
Risk of venous thromboembolism with bevacizumab in cancer patientsJavier Cortes, Cristina Saura, Francesco Atzori
Communications Medicine|May 10, 2025
Expanding screening through the use of liquid biopsy for early cancer detectionMarta Perachino, Carolina Ortiz, Javier Carmona, et al.
Breast (Edinburgh, Scotland)|April 10, 2018
HER2-positive breast cancer: Current and new therapeutic strategiesSantiago Escrivá-de-Romaní, Miriam Arumí, Meritxell Bellet, et al.
Clinical Colorectal Cancer|January 24, 2007
Novel targets for anticancer treatment development in colorectal cancerTeresa Macarulla, Francisco Javier Ramos, Jaume Capdevila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2020
Reply to T. J. A. Dekker, D.-C. Mo et al, and A. Seidman et alCristina Saura, Mafalda Oliveira, Sung-Bae Kim, et al.
Expert Review of Anticancer Therapy|September 1, 2020
Neratinib plus capecitabine for the treatment of advanced HER2-positive breast cancerMafalda Oliveira, Laia Garrigós, Juan David Assaf, et al.
Cancer Treatment Reviews|October 25, 2022
The conundrum of breast cancer and microbiome - A comprehensive review of the current evidenceAndri Papakonstantinou, Paolo Nuciforo, Maria Borrell, et al.
Pageof 16